| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00281-006-0033-4 |
| P698 | PubMed publication ID | 16964481 |
| P50 | author | Marta E Alarcón-Riquelme | Q28751753 |
| P2860 | cites work | HapMap: Building a Database with Blocks | Q73363882 |
| Identification of novel CBFA1/RUNX2 mutations causing cleidocranial dysplasia | Q77425768 | ||
| Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus | Q81129128 | ||
| Mapping common regulatory variants to human haplotypes | Q81511258 | ||
| Genome-wide associations of gene expression variation in humans | Q21145274 | ||
| Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus | Q24530690 | ||
| Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 | ||
| A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia | Q24652629 | ||
| Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation | Q24675931 | ||
| A haplotype map of the human genome | Q24679827 | ||
| The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms | Q24792586 | ||
| Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus | Q24805723 | ||
| Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice | Q57089590 | ||
| Association of PDCD1 with susceptibility to systemic lupus erythematosus | Q57307140 | ||
| Fine Mapping of the SLEB2 Locus Involved in Susceptibility to Systemic Lupus Erythematosus | Q57350921 | ||
| The genetics of systemic lupus erythematosus | Q57461969 | ||
| A RUNX trio with a taste for autoimmunity | Q57461999 | ||
| A Susceptibility Locus for Human Systemic Lupus Erythematosus (hSLE1) on Chromosome 2q | Q57462046 | ||
| Polygenic control of susceptibility to murine systemic lupus erythematosus | Q57903408 | ||
| Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus | Q61050853 | ||
| Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p | Q61070967 | ||
| Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE) | Q72785419 | ||
| Perspectives on human genetic variation from the HapMap Project. | Q24810962 | ||
| Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor | Q28144319 | ||
| Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes | Q28184518 | ||
| Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice | Q28201627 | ||
| PD-L2 is a second ligand for PD-1 and inhibits T cell activation | Q28202471 | ||
| PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2 | Q28202803 | ||
| A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms | Q28203288 | ||
| Population stratification and spurious allelic association | Q28211105 | ||
| A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans | Q28211167 | ||
| Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | Q28212039 | ||
| A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus | Q28236839 | ||
| Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes | Q28237016 | ||
| Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study | Q28237787 | ||
| Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function | Q28243036 | ||
| A genome-wide search for human type 1 diabetes susceptibility genes | Q28247197 | ||
| A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes | Q28248848 | ||
| Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus | Q28250589 | ||
| Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus | Q28254474 | ||
| SLC22A4 and RUNX1: identification of RA susceptible genes | Q28265809 | ||
| Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope | Q28266117 | ||
| A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis | Q28267921 | ||
| Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. | Q28273794 | ||
| Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies | Q28278154 | ||
| Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant | Q28280659 | ||
| A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients | Q28280744 | ||
| Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes | Q28282689 | ||
| Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus | Q28289699 | ||
| Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes | Q28300110 | ||
| Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus | Q28301821 | ||
| Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors | Q28303818 | ||
| Structure and chromosomal localization of the human PD-1 gene (PDCD1) | Q28307081 | ||
| Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia | Q28591205 | ||
| A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families | Q28776415 | ||
| Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees | Q28776419 | ||
| Interferon and granulopoiesis signatures in systemic lupus erythematosus blood | Q29615064 | ||
| The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1. | Q30160168 | ||
| Isolation and characterization of runxa and runxb, zebrafish members of the runt family of transcriptional regulators | Q30719749 | ||
| An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets | Q31014617 | ||
| Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells | Q33742099 | ||
| Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation | Q33862993 | ||
| Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease | Q33906792 | ||
| Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes | Q33920287 | ||
| Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. | Q33942125 | ||
| PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine | Q33950150 | ||
| Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis | Q34052123 | ||
| Association study designs for complex diseases | Q34186026 | ||
| Smad-Runx interactions during chondrocyte maturation | Q34192311 | ||
| An etiopathogenic role for the type I IFN system in SLE. | Q34319930 | ||
| Use of unlinked genetic markers to detect population stratification in association studies. | Q34390859 | ||
| Mapping determinants of human gene expression by regional and genome-wide association | Q34421244 | ||
| Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice | Q34507508 | ||
| Case-control studies of association in structured or admixed populations. | Q34539216 | ||
| A PD-1 polymorphism is associated with disease progression in multiple sclerosis. | Q34557891 | ||
| The natural interferon-alpha producing cells in systemic lupus erythematosus | Q35024789 | ||
| Upstream and downstream targets of RUNX proteins. | Q35102286 | ||
| Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis | Q35146679 | ||
| Microarray analysis of interferon-regulated genes in SLE. | Q35675519 | ||
| Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins | Q35779701 | ||
| Lupus susceptibility loci in New Zealand mice | Q35836652 | ||
| Combinatorial interactions of Serpent, Lozenge, and U-shaped regulate crystal cell lineage commitment during Drosophila hematopoiesis | Q36161044 | ||
| Structural variants: changing the landscape of chromosomes and design of disease studies | Q36465163 | ||
| Influence of human genome polymorphism on gene expression | Q36465182 | ||
| The cDNA cloning of the transcripts of human PEBP2alphaA/CBFA1 mapped to 6p12.3-p21.1, the locus for cleidocranial dysplasia | Q36872539 | ||
| Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus | Q36984523 | ||
| Runt domain factor (Runx)-dependent effects on CCAAT/ enhancer-binding protein delta expression and activity in osteoblasts | Q38312458 | ||
| Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex | Q38344674 | ||
| The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons | Q39644959 | ||
| Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells | Q40395229 | ||
| Genetic Contributions to Lupus‐like Disease in (NZB×NZW)F1 Mice | Q40433254 | ||
| Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation | Q40734155 | ||
| Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families | Q41612386 | ||
| The Runx1 transcription factor inhibits the differentiation of naive CD4+ T cells into the Th2 lineage by repressing GATA3 expression | Q42113879 | ||
| The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis | Q42949420 | ||
| Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. | Q43715840 | ||
| A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. | Q44506552 | ||
| A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families | Q45138861 | ||
| The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease | Q45142894 | ||
| Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases | Q46368513 | ||
| Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. | Q46375999 | ||
| Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease | Q46574356 | ||
| Gaining insight into PTPN22 and autoimmunity | Q46825387 | ||
| Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes | Q47914889 | ||
| Power tools for human genetics | Q48111196 | ||
| PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. | Q51995665 | ||
| Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. | Q52111650 | ||
| Overlapping BXSB congenic intervals, in combination with microarray gene expression, reveal novel lupus candidate genes | Q57089471 | ||
| Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice | Q57089565 | ||
| P433 | issue | 2 | |
| P921 | main subject | lupus erythematosus | Q188297 |
| systemic lupus erythematosus | Q1485 | ||
| P304 | page(s) | 109-117 | |
| P577 | publication date | 2006-09-09 | |
| P1433 | published in | Seminars in Immunopathology | Q15724576 |
| P1476 | title | The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility | |
| P478 | volume | 28 |
| Q54503537 | Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. |
| Q33455772 | Association of the BANK 1 R61H variant with systemic lupus erythematosus in Americans of European and African ancestry. |
| Q46801714 | Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus |
| Q41585169 | Genetic association of complement component 2 polymorphism with systemic lupus erythematosus |
| Q43416450 | No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus. |
| Q31156870 | Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews. |
| Q81563984 | Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups |
| Q53203652 | Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome? |
Search more.